Stocks
Biodesix Lifts 2026 Revenue Outlook to $108M-$114M
Biodesix (BDSX) raises its 2026 revenue forecast to $108M-$114M, driven by accelerated Q1 growth and expanded margins, targeting sustained adjusted EBITDA profitability.
#ebitda 3 articles
Stocks
Exponent Projects High Single-Digit Revenue Growth Fueled by AI Demand
Exponent anticipates high single-digit net revenue growth for FY 2026, projecting an EBITDA margin between 27.6% and 28.1%, driven by robust AI-related...
Stocks
Gloo Targets $190M Revenue, Q4 2026 Profitability After EMD Deal
Gloo Holdings projects $190 million in 2026 revenue and aims for adjusted EBITDA profitability by Q4 2026, following a strong Q4 fiscal...